3 insiders bought €44k of shares over the last 90 days, the latest by 이상석, filed 03 Sept 2026.
Who traded when
BuySale+4 other insiders
Since the insiders bought
- -10.3%Entry ₩10,290 · Close 30 Oct 2026 ₩9,230
- -10.3%Entry ₩10,290 · Close 30 Oct 2026 ₩9,230
- -9.1%Entry ₩10,150 · Close 30 Oct 2026 ₩9,230
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 910 sharesShareKRXDART:20260903000020Canonical exit: 2 Dec 2026 (T+90)
- 2,111 sharesShareKRXDART:20260902000090Canonical exit: 1 Dec 2026 (T+90)
- 1,872 sharesShareKRXDART:20260902000066Canonical exit: 1 Dec 2026 (T+90)
- Other0DART
- 737 sharesShareKRXDART:20260716000754Canonical exit: 11 Oct 2026 (T+90)
- 4,558 sharesShareKRXDART:20260714000112Canonical exit: 12 Oct 2026 (T+90)
- 4,708 sharesShareKRXDART:20260710000212Canonical exit: 8 Oct 2026 (T+90)
- 140,574 sharesKRXDART:20260707000231Canonical exit: 5 Oct 2026 (T+90)
- 140,574 sharesShareKRXDART:20260707000202Canonical exit: 5 Oct 2026 (T+90)
- 35,808 sharesKRXDART:20260608000233Canonical exit: 6 Sept 2026 (T+90)
- 1,193,602 sharesKRXDART:20260608000171Canonical exit: 6 Sept 2026 (T+90)
- 11,936 sharesShareKRXDART:20260608000198Canonical exit: 6 Sept 2026 (T+90)
- 23,872 sharesShareKRXDART:20260608000182Canonical exit: 6 Sept 2026 (T+90)
- 1,193,602 sharesShareKRXDART:20260608000179Canonical exit: 6 Sept 2026 (T+90)
- 718,340 shares9.51% mcap100.0% of flowKRXDART:20260508000047Canonical exit: 29 Jul 2026 (T+90)
- 1,021,143 shares13.83% mcap100.0% of flowKRXDART:20260507000371Canonical exit: 27 Jul 2026 (T+90)
- 1,021,143 sharesShareKRXDART:20260507000379Canonical exit: 27 Jul 2026 (T+90)
- 240,269 shares3.35% mcap12.3% of flowKRXDART:20260506000590Canonical exit: 27 Jul 2026 (T+90)
- 1,761,761 sharesShareKRXDART:20260506000623Canonical exit: 27 Jul 2026 (T+90)
- ●Executives0DART
- 494,784 shares3.97% mcap100.0% of flowKRXDART:20260325000873
- 363,933 shares2.34% mcap8.6% of flowKRXDART:20260320000018Canonical exit: 11 Jun 2026 (T+90)
- 1,190,679 shares7.75% mcap28.3% of flowKRXDART:20260319000761Canonical exit: 10 Jun 2026 (T+90)
25 of 46 declarations
About Celemics, Inc.
Amounts reach the tens of millions of euros at Celemics, Inc. (셀레믹스), a Korean health care company on the Korea Exchange valued at KRW 111.3 billion. Seven purchases with an amount total EUR 27,805,367 (median EUR 4,058,465) and three sales with an amount total EUR 5,458,609 (median EUR 1,741,538).
The largest purchases: EUR 8,524,450 by 수피쇼 신기술투자조합1호 on April 28, 2026, EUR 5,862,193 by 알파벳파트너스 on April 30, 2026, EUR 4,777,564 by 박종갑 (대량보유자, large holder) on March 12, 2026. On the sale side: EUR 2,448,132 by 방두희 on March 13, 2026, then EUR 1,741,538 and EUR 1,268,939 by 김효기 (공동대표이사, co-CEO) on March 12 and February 27, 2026. From June 8, 2026 to July 7, 2026, 5 filers bought.
Read moreShow less
김효기 filed 9 times, including 2 purchases and 7 sales; 박종갑 filed 12, including 7 purchases; 윤상후 (부사장) made 4 purchases. Dated trades run from February 2, 2026 to July 13, 2026, and 32 of the 43 filings are from 2026. The market side is 22 purchases and 9 sales (71% purchases). Insiders and declared holders own 25.7% of the capital. Filings appear a median of 8 days after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
